Integral Diagnostics Ltd. (AU:IDX)
Australian Market

Integral Diagnostics Ltd. Financial Statements

Integral Diagnostics Ltd. Financial Overview

Integral Diagnostics Ltd.'s market cap is currently ―. The company's EPS TTM is A$0.106; its P/E ratio is 29.15; and it has a dividend yield of 3.83%. Integral Diagnostics Ltd. is scheduled to report earnings on August 29, 2022, and the estimated EPS forecast is A$0.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 21Jun 20Jun 19
Income Statement
Total RevenueA$ 348.81MA$ 274.08MA$ 230.99M
Gross ProfitA$ 331.79MA$ 274.08MA$ 230.99M
EBITA$ 54.13MA$ 43.82MA$ 36.81M
EBITDAA$ 89.04MA$ 69.50MA$ 50.32M
Net Income Common StockholdersA$ 31.27MA$ 23.03MA$ 20.98M
Balance Sheet
Cash, Cash Equivalents and Short-Term InvestmentsA$ 20.97MA$ 57.97MA$ 62.20M
Total AssetsA$ 654.90MA$ 580.47MA$ 314.67M
Total DebtA$ 139.05MA$ 272.03MA$ 314.17M
Net DebtA$ 118.08MA$ 214.07MA$ 251.97M
Total LiabilitiesA$ 400.16MA$ 352.13MA$ 187.45M
Stockholders EquityA$ 127.22MA$ 228.33MA$ 254.74M
Cash Flow
Free Cash FlowA$ 49.30MA$ 28.37MA$ 15.25M
Operating Cash FlowA$ ―A$ ―A$ ―
Investing Cash FlowA$ -56.66MA$ -93.53MA$ -94.97M
Financing Cash FlowA$ -7.83MA$ 75.40MA$ 61.53M
Currency in AUD

Integral Diagnostics Ltd. Earnings and Revenue History

Integral Diagnostics Ltd. Debt to Assets

Integral Diagnostics Ltd. Cash Flow

Integral Diagnostics Ltd. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis